ArticleThoracic cancer2018

Development and validation of a model to predict tyrosine kinase inhibitor-sensitive EGFR mutations of non-small cell lung cancer based on multi-institutional data.

Hui Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.